✦ LIBER ✦

Risk-Benefit Assessment of Therapies forMycobacterium aviumComplex Infections

✍ Scribed by Dr David E. Griffith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-risk assessment of acne therapie

✍ Daron C Seukeran; E Anne Eady; William J Cunliffe 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 27 KB

Benefit-risk assessment of acne therapie

✍ N Bénéton; H Bocquet; A Cosnes; J Revuz; JC Roujeau 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 20 KB

Effect of Adding Clofazimine to Combined

✍ S. Fournier; A. M. Burguière; A. Flahault; V. Vincent; M. P. Treilhou; M. Eliasz 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

A Risk-Benefit Assessment of Pharmacolog

✍ Dr Enrico Carmina 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 148 KB

A Risk-Benefit Assessment of Therapies f

✍ Dr Kenneth Higby, Cheryl R. Suiter 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 254 KB

A Risk-Benefit Assessment of Therapies f

✍ Dr Dieter Schmidt, Blaise Bourgeois 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 149 KB